The Safety and Effectiveness of MK-639 and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
NCT00002443 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 780
Last updated 2005-06-24
Summary
To compare the effects on CD4 counts and safety of MK-639 (indinavir, IDV) and AZT administered concomitantly to MK-639 alone and AZT alone in HIV-1 seropositive patients.
Conditions
- HIV Infections
Interventions
- DRUG
-
Indinavir sulfate
- DRUG
-
Zidovudine
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Purpose
- TREATMENT
- Masking
- DOUBLE
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Completion
- 1996-01-31
More Related Trials
-
A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TC
NCT00002208 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety and Effectiveness of Zidovudine Plus Acyclovir in Patients With Early HIV Infection
NCT00002290 ·Status: COMPLETED ·Phase: NA
-
The Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the Disease
NCT00002324 ·Status: COMPLETED ·Phase: PHASE2
-
Initial Phase II Efficacy and Safety Study of SC-48334 Administered in Combination With Low-Dose Zidovudine (AZT) to Symptomatic HIV-1 Infected Patients With = or > 200 to = or < 500 CD4+ Cells/mm3
NCT00001993 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine
NCT00002371 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
NCT00002451 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase I Study to Evaluate the Pharmacokinetics, Safety and Antiviral Effects of Concurrent Administration of Zidovudine (AZT) and 2'3'-Dideoxyinosine (ddI) in Patients With Human Immunodeficiency Virus (HIV)
NCT00002014 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Effectiveness of an Anti-HIV Drug Combination Taken Twice Daily
NCT00002241 ·Status: UNKNOWN ·Phase: PHASE2
-
Phase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin (SC-48334) and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4+ Cells/mm3. (NOTE: Asymptomatic HIV-1 Infected Patients Also Eligible)
NCT00002079 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs
NCT00002389 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.
NCT00002199 ·Status: COMPLETED ·Phase: PHASE3
-
A Multi-Center, Placebo-Controlled, Double-Blind, Randomized Trial Comparing the Virologic and Immunologic Activities of 400 Mg Nevirapine in Combination With Zidovudine Versus Zidovudine Alone in Asymptomatic HIV-1 Infected Patients With 4-12 Months of Prior Zidovudine Therapy and 200-500 CD4+ Cell
NCT00002323 ·Status: COMPLETED ·Phase: NA
-
A Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the Past
NCT00002320 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety and Effectiveness of Zidovudine Plus Adefovir in HIV-Infected Patients
NCT00002326 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Zidovudine Plus Acyclovir in HIV-Infected Patients
NCT00001010 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
NCT00002369 ·Status: COMPLETED ·Phase: NA
-
A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV
NCT00082394 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection
NCT00001443 ·Status: COMPLETED ·Phase: PHASE1
-
Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects
NCT00000882 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Double-Blind Study of Two Doses of SC-49483 in Combination With Zidovudine (ZDV) Versus ZDV
NCT00000791 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients
NCT00002236 ·Status: COMPLETED ·Phase: NA
-
A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients
NCT00002168 ·Status: COMPLETED ·Phase: NA
-
The Safety and Effectiveness of Retrovir Plus HIVID Combined With Either Nevirapine or Invirase in the Treatment of HIV Infection
NCT00002347 ·Status: COMPLETED ·Phase: PHASE2
-
The Addition of Indinavir to Anti-HIV Treatment in HIV-Infected Patients
NCT00000861 ·Status: COMPLETED ·Phase: NA
-
The Safety of Zidovudine Plus Interferon-Alpha in HIV-Infected Children
NCT00000967 ·Status: COMPLETED ·Phase: PHASE1